Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

L Chatenoud

Showing results (51-60 of 259) with videos related to

Pageof 26
Sort By:
Transplantation Proceedings|December 1, 1990
In vivo use of OKT3: main issues for the monitoring of treated patientsL Chatenoud, C Ferran, J F Bach
Journal of Immunology (Baltimore, Md. : 1950)|March 15, 1997
CD3 antibody-induced dominant self tolerance in overtly diabetic NOD miceL Chatenoud, J Primo, J F Bach
Lancet (London, England)|July 15, 1989
In-vivo anti-CD3 treatment of autoimmune patientsL Chatenoud, C Ferran, J F Bach
Journal of Immunology (Baltimore, Md. : 1950)|April 1, 1984
The mechanisms of inhibition of human IL 2 production. II. PGE2 induction of suppressor T lymphocytesS Chouaib, L Chatenoud, D Klatzmann, et al.
Maturitas|February 25, 2000
Determinants of elevated blood pressure in women around menopause: results from a cross-sectional study in ItalyS Amigoni, P Morelli, F Parazzini, et al.
Climacteric : the Journal of the International Menopause Society|March 26, 2002
Cross-sectional study of determinants of menopausal age and hormone replacement therapy use in Italian womenS Amigoni, P Morelli, L Chatenoud, et al.
Immunology Today|September 1, 1993
Safety and efficacy of therapeutic monoclonal antibodies in clinical therapyJ F Bach, G N Fracchia, L Chatenoud
Biomedicine & Pharmacotherapy = Biomedecine & Pharmacotherapie|January 1, 1992
Pancreas and islet transplantation in manJ Timsit, C Legendre, L Chatenoud, et al.
Transplantation Proceedings|February 1, 1993
Devising murine models to better adapt clinical protocols: sequential low-dose treatment with anti-CD3 and anti-CD4 monoclonal antibodies to prevent fully mismatched allograft rejectionH H Campos, J F Bach, L Chatenoud
Pediatric Nephrology (Berlin, Germany)|June 1, 1993
Anti-OKT3 response following prophylactic treatment in paediatric kidney transplant recipientsP Niaudet, G Jean, M Broyer, et al.
Pageof 26

Showing results (51-60 of 259) with videos related to

Sort By:
Pageof 26
Transplantation Proceedings|December 1, 1990
In vivo use of OKT3: main issues for the monitoring of treated patientsL Chatenoud, C Ferran, J F Bach
Journal of Immunology (Baltimore, Md. : 1950)|March 15, 1997
CD3 antibody-induced dominant self tolerance in overtly diabetic NOD miceL Chatenoud, J Primo, J F Bach
Lancet (London, England)|July 15, 1989
In-vivo anti-CD3 treatment of autoimmune patientsL Chatenoud, C Ferran, J F Bach
Journal of Immunology (Baltimore, Md. : 1950)|April 1, 1984
The mechanisms of inhibition of human IL 2 production. II. PGE2 induction of suppressor T lymphocytesS Chouaib, L Chatenoud, D Klatzmann, et al.
Maturitas|February 25, 2000
Determinants of elevated blood pressure in women around menopause: results from a cross-sectional study in ItalyS Amigoni, P Morelli, F Parazzini, et al.
Climacteric : the Journal of the International Menopause Society|March 26, 2002
Cross-sectional study of determinants of menopausal age and hormone replacement therapy use in Italian womenS Amigoni, P Morelli, L Chatenoud, et al.
Immunology Today|September 1, 1993
Safety and efficacy of therapeutic monoclonal antibodies in clinical therapyJ F Bach, G N Fracchia, L Chatenoud
Biomedicine & Pharmacotherapy = Biomedecine & Pharmacotherapie|January 1, 1992
Pancreas and islet transplantation in manJ Timsit, C Legendre, L Chatenoud, et al.
Transplantation Proceedings|February 1, 1993
Devising murine models to better adapt clinical protocols: sequential low-dose treatment with anti-CD3 and anti-CD4 monoclonal antibodies to prevent fully mismatched allograft rejectionH H Campos, J F Bach, L Chatenoud
Pediatric Nephrology (Berlin, Germany)|June 1, 1993
Anti-OKT3 response following prophylactic treatment in paediatric kidney transplant recipientsP Niaudet, G Jean, M Broyer, et al.
Pageof 26